BCL-2 Family Proteins as Therapeutic Targets in Multiple Myeloma

Shaji Kumar, MD, and Jonathan Kaufman, MD, discuss the role of BCL-2 proteins in multiple myeloma treatment and recent safety and efficacy data on BCL-2 inhibitors.